Back to First Trust Advisors LP First Trust Advisors LP

ACADACAD

Showing 8 of 31 quarters

Position history for First Trust Advisors LPFirst Trust Advisors LP's holdings in ACADIA Pharmaceuticals Inc.

Yes. First Trust Advisors holds 184,386 shares of ACAD (ACADIA Pharmaceuticals), worth $4.7M, as of its Q2 2026 13F filing. It reduced the position by 3,159,482 shares (-94.5%) from Q1 2026. First Trust Advisors has held ACAD in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$4.7M

Current Shares

184,386

Total Value Change

-$28M

Total Shares Change

-1.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
184,386
-94.5%
$4.7M0.0%$25.30
0
2026-Q1
Increased
3.3M
+47.3%
$74.4M0.1%$22.26
41
2025-Q4
Increased
2.3M
+16.8%
$60.6M0.0%$26.71
34
2025-Q3
Decreased
1.9M
-20.2%
$41.5M0.0%$21.34
0
2025-Q2
Increased
2.4M
+2.8%
$52.5M0.0%$21.57
30
2025-Q1
Decreased
2.4M
-12.3%
$39.3M0.0%$16.61
0
2024-Q4
Increased
2.7M
+27.0%
$49.5M0.0%$18.35
36
2024-Q3
Increased
2.1M
+2.8%
$32.7M0.0%$15.38
30

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used